Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (LEIDA 2)

This study has been completed.
Siro Clinpharm Germany GmbH (until June 2013)
Accovion GmbH
Information provided by (Responsible Party):
MEDA Pharma GmbH & Co. KG Identifier:
First received: September 30, 2011
Last updated: April 2, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)